Page last updated: 2024-08-16

viloxazine and moclobemide

viloxazine has been researched along with moclobemide in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Allain, H; Brunet-Bourgin, F; Gandon, JM; Le Coz, F; Lieury, A; Mirabaud, C; Trebon, P	1
Broyer, M; Chamba, G; d'Amato, T; Dalery, J; Ghaemmaghami, C; Lestra, C; Perret-Liaudet, A; Renaud, B	1

Trials

1 trial(s) available for viloxazine and moclobemide

Article	Year
Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline. Psychopharmacology, 1992, Volume: 106 Suppl Topics: Adult; Antidepressive Agents; Arousal; Attention; Benzamides; Cognition; Depression; Double-Blind Method; Female; Humans; Male; Maprotiline; Memory; Moclobemide; Monoamine Oxidase Inhibitors; Multicenter Studies as Topic; Psychiatric Status Rating Scales; Viloxazine	1992

Article

Year

Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline.

Psychopharmacology, 1992, Volume: 106 Suppl

Topics: Adult; Antidepressive Agents; Arousal; Attention; Benzamides; Cognition; Depression; Double-Blind Method; Female; Humans; Male; Maprotiline; Memory; Moclobemide; Monoamine Oxidase Inhibitors; Multicenter Studies as Topic; Psychiatric Status Rating Scales; Viloxazine

1992

Other Studies

2 other study(ies) available for viloxazine and moclobemide

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Biological parameters in major depression: effects of paroxetine, viloxazine, moclobemide, and electroconvulsive therapy. Relation to early clinical outcome. Biological psychiatry, 1998, Aug-15, Volume: 44, Issue:4 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Benzamides; Biomarkers; Biopterins; Blood Platelets; Depressive Disorder; Drug Resistance; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin; Severity of Illness Index; Treatment Outcome; Viloxazine	1998

Article

Year

Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.

Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008

Biological parameters in major depression: effects of paroxetine, viloxazine, moclobemide, and electroconvulsive therapy. Relation to early clinical outcome.

Biological psychiatry, 1998, Aug-15, Volume: 44, Issue:4

Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Benzamides; Biomarkers; Biopterins; Blood Platelets; Depressive Disorder; Drug Resistance; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin; Severity of Illness Index; Treatment Outcome; Viloxazine

1998